Folic acid and vitamin B6 may prevent pancreatic cancer

Share This Post

A recent study published in the European Journal of Clinical Nutrition showed that diet may play a key role in preventing pancreatic cancer. The study investigated the link between pancreatic cancer risk and the intake of certain nutrients involved in methyl metabolism.

Zhang Jianjun, MD, associate professor of epidemiology at the Indiana University Fairbanks School of Public Health and senior author of the study, said: “Methylation is critical for DNA synthesis and methylation.” Methylation may be related to tumors. Formation is related to growth. Key nutrients for methyl metabolism include folic acid, vitamins B6 and B12, and methionine. The results showed that participants with the highest intake of folic acid had a 69% reduction in pancreatic cancer risk compared with those with the lowest intake. Vitamin B6 intake alone is not associated with pancreatic risk. However, when two nutrients are taken together, it is of practical significance. Large intake of folic acid and vitamin B6 can reduce the risk of pancreatic cancer by 76%.

The results of this study show that the intake of folic acid and vitamin B6 can help prevent pancreatic cancer. However, the American Cancer Institute (AICR) recommends that you get the nutrients you need from food and does not recommend the use of supplements to prevent cancer. AICR recommends eating a cancer-protective diet rich in folic acid, vitamin B6 and other nutrients to reduce the risk of cancer.

Folic acid is a water-soluble vitamin found in green leafy vegetables, beans, nuts and fruits. Vitamin B6 is present in many foods, including fortified grains, beans, poultry, fish and some vegetables and fruits, especially dark green leafy vegetables, papaya, oranges and cantaloupe.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

CAR T Cell therapy for AIDS related B Cell malignancies
Aids cancer

CAR T Cell therapy for AIDS related B-Cell malignancies

CAR T cell therapy for HIV-related B cell malignancies involves genetically modifying a patient’s T cells to express chimeric antigen receptors (CARs) targeting CD19 on B cells. This treatment holds promise in eradicating malignant B cells but must carefully manage immunosuppression in HIV-positive individuals.

Cancer statistics in India 2024
Cancer

Cancer statistics in India 2024: Incidence, estimates and projections

In 2024, cancer will remain a significant health challenge in India. The country sees over 1.5 million new cases a year. Breast and oral cancers are most prevalent among women and men, respectively. Sadly, many cases are diagnosed late, impacting survival rates. Improved awareness and access to healthcare are crucial. By 2030, cancer incidence is expected to surpass 1.7 million cases annually. Efforts to enhance prevention, early detection, and treatment access are crucial to mitigate this growing burden. Check our cancer statistics in India for 2024 and future projections.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
Need help with cancer treatment?
Scan the code
Hello,
Welcome to CancerFax !

CancerFax is the most trusted international patient facilitator working with top cancer hospital's in the world like MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Beijing Cancer Institute and Apollo to bring you best of therapies and drugs.

Let us know what services would you like to avail?

1) Cancer treatment in the USA, Japan, Israel, India, Korea or Singapore?
2) CAR T-Cell therapy treatment
3) Cancer vaccine
4) Online video consultation
5) Proton therapy